Clinical Sponsor Intel

{
  "competitive_position": "Global leader in RNAi therapeutics. 6 approved drugs. Patent portfolio dominant through 2035+.",
  "fda_approvals": [
    {
      "approved": "2018",
      "drug": "Patisiran (Onpattro)",
      "first_in_class": true,
      "indication": "hATTR polyneuropathy",
      "type": "NDA"
    },
    {
      "approved": "2019",
      "drug": "Givosiran (Givlaari)",
      "indication": "Acute hepatic porphyria",
      "type": "NDA"
    }
  ],
  "investment_signals": {
    "near_term_catalysts": [
      "HELIOS-B ATTR-CM readout 2025",
      "ALN-APP Phase 2 for early Alzheimer's"
    ],
    "pipeline_value_estimate": "$12-18B risk-adjusted NPV",
    "risks": [
      "Pricing pressure in rare disease",
      "RNAi delivery competition from Arrowhead"
    ]
  },
  "partnership_activity": "Novartis partnership (inclisiran, cardiovascular) — $9.7B deal. Roche collaborations ongoing. Regeneron RNAi collaboration $400M+.",
  "phase3_assets": [
    {
      "completion": "2025-Q3",
      "condition": "ATTR Cardiomyopathy",
      "drug": "Vutrisiran (Amvuttra)",
      "nctId": "NCT04153149",
      "significance": "Key label expansion into ATTR-CM — $3B+ market",
      "status": "ACTIVE_NOT_RECRUITING"
    }
  ],
  "pipeline_summary": {
    "phase1_count": 8,
    "phase2_count": 9,
    "phase3_count": 6,
    "primary_therapeutic_areas": [
      "Rare genetic diseases (TTR, PH1, AHP)",
      "Cardiovascular (inclisiran)",
      "CNS (Huntington's)"
    ],
    "total_active_trials": 23
  },
  "query_summary": {
    "focus": "all",
    "sponsor": "Alnylam Pharmaceuticals"
  }
}

# bash or zsh: see the payment challenge. Nothing is charged.
curl -sS -g -i 'https://clinicalintelpulse.theaslangroupllc.com/api/clinical/sponsor-intel?focus=pipeline+%7C+approvals+%7C+deals+%7C+all+%28default%3A+all%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29&sponsor=Company+name+%E2%80%94+e.g.+%22Moderna%22+%7C+%22BioNTech%22+%7C+%22Alnylam%22+%7C+%22Vertex+Pharmaceuticals%22+%7C+%22Regeneron%22'

# x402 v2 sends the challenge base64-encoded in the PAYMENT-REQUIRED header (v1 sends it in the body).
# To read the header:
curl -sS -g -o /dev/null -D - 'https://clinicalintelpulse.theaslangroupllc.com/api/clinical/sponsor-intel?focus=pipeline+%7C+approvals+%7C+deals+%7C+all+%28default%3A+all%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29&sponsor=Company+name+%E2%80%94+e.g.+%22Moderna%22+%7C+%22BioNTech%22+%7C+%22Alnylam%22+%7C+%22Vertex+Pharmaceuticals%22+%7C+%22Regeneron%22' \
  | grep -i '^payment-required:' | cut -d' ' -f2 | tr -d '\r' | base64 --decode

// npm i @x402/fetch @x402/evm viem
import { wrapFetchWithPayment, x402Client } from "@x402/fetch";
import { registerExactEvmScheme } from "@x402/evm/exact/client";
import { privateKeyToAccount } from "viem/accounts";

// Pays at most $0.2 per call.
const client = new x402Client().setSpendControls({ maxAmountPerPayment: "$0.2" });
registerExactEvmScheme(client, { signer: privateKeyToAccount(process.env.EVM_PRIVATE_KEY) });
const pay = wrapFetchWithPayment(fetch, client);

// Not sure it's safe to pay? ToolVet checks it first for $0.005. Pay for that from a separate
// client: this one is capped at $0.2 per payment. GET https://toolvet.app/api/v1/check?url=https%3A%2F%2Fclinicalintelpulse.theaslangroupllc.com%2Fapi%2Fclinical%2Fsponsor-intel
const res = await pay("https://clinicalintelpulse.theaslangroupllc.com/api/clinical/sponsor-intel?focus=pipeline+%7C+approvals+%7C+deals+%7C+all+%28default%3A+all%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29&sponsor=Company+name+%E2%80%94+e.g.+%22Moderna%22+%7C+%22BioNTech%22+%7C+%22Alnylam%22+%7C+%22Vertex+Pharmaceuticals%22+%7C+%22Regeneron%22");
console.log(res.status, await res.text());

# pip install "x402[requests,evm]"
import os
from eth_account import Account
from x402 import x402ClientSync
from x402.http.clients import x402_requests
from x402.mechanisms.evm import EthAccountSigner
from x402.mechanisms.evm.exact.register import register_exact_evm_client

# Pays at most $0.2 per call.
client = x402ClientSync().set_spend_controls({"max_amount_per_payment": "$0.2"})
register_exact_evm_client(client, EthAccountSigner(Account.from_key(os.environ["EVM_PRIVATE_KEY"])))

with x402_requests(client) as session:
    res = session.get("https://clinicalintelpulse.theaslangroupllc.com/api/clinical/sponsor-intel?focus=pipeline+%7C+approvals+%7C+deals+%7C+all+%28default%3A+all%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29&sponsor=Company+name+%E2%80%94+e.g.+%22Moderna%22+%7C+%22BioNTech%22+%7C+%22Alnylam%22+%7C+%22Vertex+Pharmaceuticals%22+%7C+%22Regeneron%22")
    print(res.status_code, res.text)